Cygnus Technologies
Cygnus Technologies specializes in providing analytical products and services to the pharmaceutical and biotechnology sectors, focusing on the development of therapeutic proteins, vaccines, antibodies, and gene therapies. The company offers a range of generic kits and immunoassay reagents specifically designed for bioprocess contaminant testing, with an emphasis on host cell protein detection in recombinant pharmaceuticals. Additionally, Cygnus Technologies delivers custom antibody and assay development services, which include antibody purification, conjugation, and the creation of tailored assays for quality control and process development. Their product offerings also encompass ELISA kits, DNA detection products, Western blot kits, and immunogenicity analysis products, enabling clients to enhance their research and development efforts effectively.
MockV Solutions
Acquisition in 2020
MockV Solutions, Inc. is a biotechnology company based in Rockville, Maryland, specializing in the development of non-infectious mock virus particles (MVP) that replicate the characteristics of live infectious viruses. These particles serve as spiking agents during the analysis of live viruses, facilitating accurate testing and evaluation. Founded in 2015, MockV Solutions also creates a range of analytical kits designed to assist benchtop scientists in quantifying viral clearance in industrial processes efficiently and cost-effectively. As of March 2020, the company operates as a subsidiary of Maravai Life Sciences Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.